Literature DB >> 1519288

Prevention of postischemic canine neurological injury through potentiation of brain energy metabolism by acetyl-L-carnitine.

R E Rosenthal1, R Williams, Y E Bogaert, P R Getson, G Fiskum.   

Abstract

BACKGROUND AND
PURPOSE: Mechanisms of ischemia/reperfusion brain injury include altered patterns of energy metabolism that may be amenable to pharmacological manipulation. The purpose of this study was to test the effectiveness of postischemic acetyl-L-carnitine administration on potentiation of metabolic recovery and prevention of neurological morbidity in a clinically relevant model of complete, global cerebral ischemia and reperfusion.
METHODS: Neurological deficit scoring as well as spectrophotometric and fluorescent assays of frontal cortex lactate and pyruvate levels were used in a canine model employing 10 minutes of cardiac arrest followed by restoration of spontaneous circulation for 2 or 24 hours.
RESULTS: Dogs treated with acetyl-L-carnitine exhibited significantly lower neurological deficit scores (p = 0.0037) and more normal cerebral cortex lactate/pyruvate ratios than did vehicle-treated control animals.
CONCLUSIONS: Postischemic administration of acetyl-L-carnitine potentiates normalization of brain energy metabolites and substantially improves neurological outcome in a clinically relevant model of global cerebral ischemia and reperfusion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1519288     DOI: 10.1161/01.str.23.9.1312

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  41 in total

Review 1.  Novel mitochondrial targets for neuroprotection.

Authors:  Miguel A Perez-Pinzon; R Anne Stetler; Gary Fiskum
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-28       Impact factor: 6.200

Review 2.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

3.  Hyperoxic reperfusion after global ischemia decreases hippocampal energy metabolism.

Authors:  Erica M Richards; Gary Fiskum; Robert E Rosenthal; Irene Hopkins; Mary C McKenna
Journal:  Stroke       Date:  2007-04-05       Impact factor: 7.914

4.  Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain.

Authors:  Susanna Scafidi; Gary Fiskum; Steven L Lindauer; Penelope Bamford; Da Shi; Irene Hopkins; Mary C McKenna
Journal:  J Neurochem       Date:  2010-05-13       Impact factor: 5.372

Review 5.  L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.

Authors:  Gustavo C Ferreira; Mary C McKenna
Journal:  Neurochem Res       Date:  2017-05-16       Impact factor: 3.996

6.  Augmentation of normal and glutamate-impaired neuronal respiratory capacity by exogenous alternative biofuels.

Authors:  Melissa D Laird; Pascaline Clerc; Brian M Polster; Gary Fiskum
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

Review 7.  Postischemic oxidative stress promotes mitochondrial metabolic failure in neurons and astrocytes.

Authors:  Gary Fiskum; Camelia A Danilov; Zara Mehrabian; Linda L Bambrick; Tibor Kristian; Mary C McKenna; Irene Hopkins; E M Richards; Robert E Rosenthal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 8.  Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

9.  Sex-dependent mitochondrial respiratory impairment and oxidative stress in a rat model of neonatal hypoxic-ischemic encephalopathy.

Authors:  Tyler G Demarest; Rosemary A Schuh; Jaylyn Waddell; Mary C McKenna; Gary Fiskum
Journal:  J Neurochem       Date:  2016-05-06       Impact factor: 5.372

Review 10.  Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.

Authors:  Carmen Mingorance; Rosalía Rodríguez-Rodríguez; María Luisa Justo; María Alvarez de Sotomayor; María Dolores Herrera
Journal:  Vasc Health Risk Manag       Date:  2011-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.